Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* older than 18 years old~* prehospital moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5~Exclusion Criteria:~* unstable vital signs (systolic blood pressure \<90 or \>200 mm Hg, pulse rate \<50 or \>150 beats/min, and respiration rate \<10 or \>30 breaths/min)~* pregnancy~* breast-feeding~* altered mental status~* unable to give numeric rating scale scores~* allergy to morphine or ketamine~* acute pulmonary edema~* acute coronary syndrome~* renal or hepatic insufficiency~* patient who received morphine for the same acute pain~* acute psychiatric illness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ketamine IV (Type: EXPERIMENTAL): None
- Morphine IV (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).